智通财经APP讯,瑛泰医疗(01501)发布截至2026年6月30日止6个月中期业绩,该集团取得收入5.96亿元,同比增加29.28%;公司权益股东应占利润1.1亿元,同比增加11.97%;每股盈利0.54元。
公告称,收入增加主要是由于收购及并购填补了产品缺口,构建了完整的产品品类矩阵;以及透过渠道复用及供应链整合实现协同效应,从而推动介入医疗器械销量增长所致。
智通财经APP讯,瑛泰医疗(01501)发布截至2026年6月30日止6个月中期业绩,该集团取得收入5.96亿元,同比增加29.28%;公司权益股东应占利润1.1亿元,同比增加11.97%;每股盈利0.54元。
公告称,收入增加主要是由于收购及并购填补了产品缺口,构建了完整的产品品类矩阵;以及透过渠道复用及供应链整合实现协同效应,从而推动介入医疗器械销量增长所致。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.